Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improved vessel dilator for percutaneous catheterization.

T P Smith, Z Vlodaver, M D Darcy

    Radiology
    |April 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Axillary web syndrome following breast cancer surgery: symptoms, complications, and management strategies.

    Breast cancer (Dove Medical Press)·2018
    Same author

    Lymphspiration: The Axillary Web and Its Lymphatic Origin.

    Lymphology·2018
    Same author

    Characterizing axillary web syndrome: ultrasonographic efficacy.

    Lymphology·2015
    Same author

    Preventing contrast-induced nephropathy with fenoldopam.

    Techniques in vascular and interventional radiology·2002
    Same author

    Experimental evaluation of a modified Amplatzer duct occluder.

    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
    Same author

    MR-guided percutaneous drainage of abdominal fluid collections in combination with X-ray fluoroscopy: initial clinical experience.

    European radiology·2001
    Same journal

    Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

    Radiology·2026
    Same journal

    Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

    Radiology·2026
    Same journal

    Erratum for: Blue Rubber Bleb Nevus Syndrome.

    Radiology·2026
    Same journal

    Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

    Radiology·2026
    Same journal

    To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

    Radiology·2026
    Same journal

    The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

    Radiology·2026
    See all related articles

    An improved vessel dilator design significantly reduces arterial damage during percutaneous catheterization compared to commercial options. This enhanced design offers safer vessel access for medical procedures.

    Area of Science:

    • Cardiovascular research
    • Medical device engineering
    • Surgical innovation

    Background:

    • Percutaneous catheterization is a vital medical procedure.
    • Vessel dilators are crucial tools for arterial access.
    • Existing commercial dilators may cause significant arterial damage.

    Purpose of the Study:

    • To compare the arterial damage caused by commercial vessel dilators versus an improved design.
    • To evaluate the safety and efficacy of the improved dilator in a preclinical setting.
    • To assess the long-term clinical performance of the improved dilator.

    Main Methods:

    • Comparative study using 16 mongrel dogs.
    • Testing of three commercial vessel dilators and one improved design.
    • Evaluation of arterial damage post-percutaneous catheterization.

    Related Experiment Videos

    Main Results:

    • All tested dilators caused some degree of arterial damage.
    • The improved vessel dilator design resulted in significantly less arterial damage.
    • Lesions associated with the improved design were less severe overall.

    Conclusions:

    • The improved vessel dilator design offers a safer alternative for percutaneous catheterization.
    • The enhanced design minimizes trauma to arterial walls.
    • The dilator has a proven 30-year track record of safe clinical use.